Gary E. Zurenko - Concepedia

Author

Gary E. Zurenko

W.E. Upjohn Institute for Employment Research

Also Known As

G E Zurenko, G. E. ZURENKO, G. E. Zurenko, G. Zurenko, G.E. Zurenko, GARY E. ZURENKO, Gary E Zurenko, Gary E. Zurenko, Gary Zurenko, Zurenko, G.E.

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research Pfizer (United States)

About

Gary E. Zurenko is an author at W.E. Upjohn Institute for Employment Research specializing in pharmacology, medicine, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	35	2.2K
2	Health Sciences	10	10	533
3	Natural Sciences	10	10	343
4	Biochemistry	8	8	249
5	Engineering	3	3	271

Gary E. Zurenko

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Substituent Effects on the Antibacterial Activity of Nitrogen−Carbon-Linked (Azolylphenyl)oxazolidinones with Expanded Activity Against the Fastidious Gram-Negative Organisms <i>Haemophilus </i><i>i</i><i>nfluenzae</i> and <i>Moraxella </i><i>c</i><i>atarrhalis</i> Michaël Génin, Debra A. Allwine, David Anderson, Journal of Medicinal Chemistry	2000	722
Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections Steven J. Brickner, Douglas K. Hutchinson, Michael R. Barbachyn, Journal of Medicinal Chemistry Antibacterial ActivityAntimicrobial ChemotherapyDrug ResistanceMycobacterium TuberculosisAntimicrobial Therapy	1996	570
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents Gary E. Zurenko, Betty H. Yagi, Ronda D. Schaadt, Antimicrobial Agents and Chemotherapy	1996	461
Identification of a Novel Oxazolidinone (U-100480) with Potent Antimycobacterial Activity Michael R. Barbachyn, Douglas K. Hutchinson, Steven J. Brickner, Journal of Medicinal Chemistry	1996	234
In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains Karen Joy Shaw, Susan M. Poppe, Ronda D. Schaadt, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyVitro SensitivityAntibiotic ResistanceDrug ResistanceMedicinal Chemistry	2008	179
Marine natural products as sources of antiviral, antimicrobial, and antineoplastic agents K. L. Rinehart, Paul D. Shaw, Lois S. Shield, Pure and Applied Chemistry Marine BiotechnologyEngineeringAntineoplastic AgentsMarine Natural ProductsMedicine	1981	169
In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent Ronda D. Schaadt, Debora Sweeney, Dean L. Shinabarger, Antimicrobial Agents and Chemotherapy Vitro PotencyAntimicrobial ChemotherapyMic AssaysMedicinal ChemistryInfection Control	2009	115
Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria Wolfgang Haas, Chris M. Pillar, Gary E. Zurenko, Antimicrobial Agents and Chemotherapy Antibacterial SpectrumHealth SciencesAntibioticsAntimicrobial SusceptibilityMedicine	2009	102
Piperazinyl Oxazolidinone Antibacterial Agents Containing a Pyridine, Diazene, or Triazene Heteroaromatic Ring John A. Tucker, Debra A. Allwine, Kevin C. Grega, Journal of Medicinal Chemistry	1998	91
In Vitro Activities of Linezolid Combined with Other Antimicrobial Agents against Staphylococci, Enterococci, Pneumococci, and Selected Gram-Negative Organisms Michael T. Sweeney, Gary E. Zurenko Antimicrobial Agents and Chemotherapy	2003	89

Page 1